Salivary Proteomics Identifies Transthyretin as a Biomarker of Early Dementia Conversion
Open Access
- 19 January 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 6 (1) , 31-41
Abstract
Background: Alzheimer’s disease (AD) remains to date an incurable disease with a long asymptomatic phase. Early diagnosis in peripheral biofluids has emerged as key for identifying subjects at risk and developing therapeutics and preventative approaches. Objective: We apply proteomics discovery to identify salivary diagnostic biomarkers for AD, which are suitable for self-sampling and longitudinal biomonitoring during aging. Methods: 57 participants were recruited for the study and were categorized into Cognitively normal (CNh) ( n = 19), mild cognitive impaired (MCI) ( n = 21), and Alzheimer’s disease (AD) ( n = 17). On a subset of subjects, 3 CNh and 3 mild AD, shot-gun filter aided sample preparation (FASP) proteomics and liquid chromatography mass spectroscopy (LC-MS/MS) was employed in saliva and cerebrospinal fluid (CSF) to identify neural-derived proteins. The protein level of salivary Transthyretin (TTR) was validated using western blot analysis across groups. Results: We found that 19.8% of the proteins in saliva are shared with CSF. When we compared the saliva and CSF proteome, 24 hits were decreased with only one protein expressed more. Among the differentially expressed proteins, TTR with reported function in amyloid misfolding, shows a significant drop in AD samples, confirmed by western blot showing a 0.5-fold reduction in MCI and AD compared to CNh. Conclusion: A reduction in salivary TTR appears with the onset of cognitive symptoms. More in general, the proteomic profiling of saliva shows a plethora of biomarkers worth pursuing as non-invasive hallmarks of dementia in the preclinical stage.Keywords
This publication has 61 references indexed in Scilit:
- Association of Plasma β-Amyloid Level and Cognitive Reserve With Subsequent Cognitive DeclineJAMA, 2011
- Improved visualization of low abundance oral fluid proteins after triple depletion of alpha amylase, albumin and IgGOral Diseases, 2010
- Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot studyBMC Neurology, 2010
- Universal sample preparation method for proteome analysisNature Methods, 2009
- Combining Early Markers Strongly Predicts Conversion from Mild Cognitive Impairment to Alzheimer's DiseaseBiological Psychiatry, 2008
- The Proteomes of Human Parotid and Submandibular/Sublingual Gland Salivas Collected as the Ductal SecretionsJournal of Proteome Research, 2008
- Saliva: a Dynamic ProteomeJournal of Dental Research, 2007
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- A PECULIAR FORM OF PERIPHERAL NEUROPATHYBrain, 1952